152 related articles for article (PubMed ID: 1674390)
1. [The role of prostaglandins in the effect of beta-blockers on stimulated blood platelets].
Nosál' R; Jancinová V; Petríková M
Vnitr Lek; 1991 Mar; 37(3):261-7. PubMed ID: 1674390
[TBL] [Abstract][Full Text] [Related]
2. Alterations in lipid peroxidation of thrombin-stimulated rat platelets treated with beta-adrenoceptor blocking drugs.
Nosál R; Petríková M; Jancinová V
J Lipid Mediat; 1993 Oct; 8(2):121-32. PubMed ID: 7903565
[TBL] [Abstract][Full Text] [Related]
3. Carvedilol--a beta-blocker with considerable antiaggregatory effect on human blood platelets.
Petrikova M; Jancinova V; Nosal R; Majekova M; Fabryova V
Bratisl Lek Listy; 2005; 106(1):20-5. PubMed ID: 15869009
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by osthole from Angelica pubescens.
Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM
Thromb Haemost; 1989 Nov; 62(3):996-9. PubMed ID: 2556815
[TBL] [Abstract][Full Text] [Related]
5. The effect of oral ticlopidine on arachidonic acid products in human platelets.
Bruno JJ; Chang LF; McSpadden MM; Yang D
Agents Actions Suppl; 1984; 15():76-87. PubMed ID: 6435408
[No Abstract] [Full Text] [Related]
6. Comparison of the effects of carvedilol, propranolol, and verapamil on in vitro platelet function in healthy volunteers.
Gasser JA; Betterridge DJ
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S29-34. PubMed ID: 1721976
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of the effects of adrenoceptor antagonists on platelet aggregation and thromboxane generation.
Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD
Thromb Haemost; 1985 Aug; 54(2):480-4. PubMed ID: 2867620
[TBL] [Abstract][Full Text] [Related]
8. Effects of CI-930, a novel phosphodiesterase III inhibitor, on platelet aggregation and arachidonic acid metabolism.
Chen XS; Zeng HW; Jiang YY; Wan WQ; Long K
Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):338-43. PubMed ID: 1966575
[TBL] [Abstract][Full Text] [Related]
9. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil.
Han P; Boatwright C; Ardlie NG
Thromb Haemost; 1983 Aug; 50(2):513-7. PubMed ID: 6314581
[TBL] [Abstract][Full Text] [Related]
10. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
[TBL] [Abstract][Full Text] [Related]
11. On the relationship between the inhibition of thrombin stimulated aggregation and thromboxane formation in isolated platelets treated with beta-adrenoceptor blocking drugs.
Nosál R; Jancinová V; Petríková M
Thromb Res; 1992 Dec; 68(4-5):333-44. PubMed ID: 1363256
[TBL] [Abstract][Full Text] [Related]
12. Influence of some beta blockers (pindolol, atenolol, timolol and metoprolol) on aggregation and arachidonic acid metabolism in human platelets.
Srivastava KC
Prostaglandins Leukot Med; 1987 Sep; 29(1):79-84. PubMed ID: 2890173
[TBL] [Abstract][Full Text] [Related]
13. Exercise-induced increase in plasma arachidonic acid and thromboxane B2 in healthy men: effect of beta-adrenergic blockade.
Laustiola K; Seppälä E; Nikkari T; Vapaatalo H
J Cardiovasc Pharmacol; 1984; 6(3):449-54. PubMed ID: 6202971
[TBL] [Abstract][Full Text] [Related]
14. Mepacrine blockade of arachidonate-induced washed platelet aggregation: relationship to mepacrine inhibition of platelet cyclooxygenase.
Raz A
Thromb Haemost; 1983 Dec; 50(4):784-6. PubMed ID: 6420923
[TBL] [Abstract][Full Text] [Related]
15. The influence of PAF on the metabolization of arachidonic acid by human blood platelets.
Ostermann G; Block HU; Till U
Biomed Biochim Acta; 1984; 43(8-9):S323-6. PubMed ID: 6440547
[TBL] [Abstract][Full Text] [Related]
16. Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs.
Maguire MH; Csonka-Khalifah L
Biochim Biophys Acta; 1987 Oct; 921(3):426-36. PubMed ID: 3117116
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of platelet function of antiarrhythmic drugs, verapamil and disopyramide.
Han P; Boatwright C; Ardlie NG
Thromb Haemost; 1982 Apr; 47(2):150-3. PubMed ID: 7101234
[TBL] [Abstract][Full Text] [Related]
18. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane production by platelets during tumor cell-induced platelet activation.
Pacchiarini L; Zucchella M; Milanesi G; Tacconi F; Bonomi E; Canevari A; Grignani G
Invasion Metastasis; 1991; 11(2):102-9. PubMed ID: 1917383
[TBL] [Abstract][Full Text] [Related]
20. Effects of magnesium lithospermate B on aggregation and 5-HT release in rabbit washed platelets.
Wang W; Wang YP; Sun WK; Xu YM; Xuan LJ
Acta Pharmacol Sin; 2000 Sep; 21(9):859-63. PubMed ID: 11501172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
